Search
Search Constraints
You searched for: Author/Creator Stella, StefaniaLimit your search
- Stella, Stefania [remove] 5
- Hematology -- Periodicals 2
- Oncology -- Periodicals 2
- 616.135 1
- 616.15 1
- 616.994 1
- 616.99405 1
- 616.99406 1
- BYL719 alpelisib -- CDK 4/6 ciclin dependent kinase 4/6 -- FoxO Forkhead box protein O -- GDC-0032 taselisib -- GDC-0941 pictilisib -- IL-8 interleukin-8 -- NEK9 serine/threonine-protein kinase Nek9 -- p27Kip1 p27 kinase inhibitory protein 1 -- PDK1 3-phosphoinositide dependent kinase-1 -- RHEB RAS homolog enriched in brain -- S6K1 ribosomal protein S6 kinase -- 4E-BP1 eIF4E binding protein 1 -- AP-1 transcription factor subunit -- AP-1 activator protein-1 -- BAD BCL2 associated agonist of cell death -- BAX BCL2 associated X;BAY80-6946: copanlisib -- BCL2 B-cell lymphoma 2 -- BET Bromo- and Extra-Terminal proteins -- BKM-120 buparlisb -- c-JUN Jun proto-oncogene, COSMIC: Catalogue of Somatic Mutations in Cancer -- EGFR epidermal growth factor receptor -- eIF4E eukaryotic translation initiation factor 4E -- EMT epithelial to mesenchymal transition -- ERKs extracellular signal-regulated kinases -- ESCC esophageal squamous cell carcinomas -- FGFR fibroblast growth factor receptors -- FOS complex consisting of FBJ murine osteosarcoma viral oncogene -- FOSL1 FOS ligand 1 -- FOXO3 Forkhead box O3 -- GPCR G-protein coupled receptor -- GSK3b b-catenin signaling -- GSK3α/ β glycogen synthase kinase-3 α/ β -- GTPases related guanosine triphosphatases -- HER2- human epidermal growth factor receptor 2 negative -- HER3 human epidermal growth factor receptor 3 -- HNSCC head and neck squamous cell carcinomas -- HR+ hormone receptor positive -- IGF-1R insulin growth factor-1 receptor -- IL-6 interleukin-6 -- INPP4B inositol polyphosphate-4-phosphatase type II B -- IRS-1/2 insulin receptor substrate 1/2 -- IRS-2 insulin receptor substrate 2 -- JAKs Janus family of kinases -- MAPK mitogen-activated protein kinase -- MDM2 mouse double minute 2 homolog -- MEK mitogen-activated protein kinase kinase (MEK) -- mTOR mammalian target of rapamycin -- P21 Proto-Oncogene protein P21 -- PDX patient-derived xenograft -- PI3K phosphatidylinositol 3-kinase -- Pim1 proto-oncogene, serine/threonine kinase (PIM1) -- PIP2 phosphatidylinositol (4, 5)-bisphosphate -- PIP3 phosphatidylinositol (3, 4, 5)-trisphosphate -- PKB/AKT protein kinase B -- PLCg/PKC phospholipase Cg-protein kinase C -- JNK c-Jun N-terminal kinases -- PTEN phosphatase and tensin homolog -- RAS small rat sarcoma -- RSK3 ribosomal S6 kinases RPS6KA2 -- RSK4 ribosomal S6 kinases RPS6KA6 -- RTK receptor-coupled tyrosine kinases -- SGK1 serum/glucocorticoid regulated kinase 1 -- SH2 SRC Homology 2 domain -- SHIP1 SH2 domain-containing inositol polyphosphate 5-phosphatase 1 -- SKP2 S-phase kinase-associated protein 2 -- STATs signal transducers and activators of transcription -- TCF7 Transcription Factor 7 -- TNBC triple negative breast cancer -- TORC1 mTOR/Raptor complex -- TORC2 mTOR/Rictor complex -- TSC1/2 tuberous sclerosis complex 1 and 2;TSC2: TSC complex subunit 2 -- WGS whole genome sequencing -- WNT Wingless-type MMTV integration site family 1
- Blood -- Diseases -- Periodicals 1
- CALGB score -- EORTC score -- FDG-PET -- fibulin-3 -- gene arrays -- Ki-67 -- malignant pleural mesothelioma -- mesothelin -- NRL -- nuclear grading score 1